-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on Corteva, Raises Price Target to $90

Benzinga·09/16/2026 13:09:12
Listen to the news
UBS analyst Joshua Spector maintains Corteva (NYSE:CTVA) with a Neutral and raises the price target from $85 to $90.